Ocular-Hypertensive and Anti-inflammatory Response to Rimexolone Therapy in Children

Archives of Ophthalmology

Volumn 121, Issue 12, 2003, Pages 1716-1721

  Fan, Dorothy S P ^a   Yu, Christopher B O ^a   Chiu, Thomas Y H ^a   Wong, Chun Yu ^b   Ng, Joan S K ^b   Pang, Chi Pui ^a   Lam, Dennis S C ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROMETHOLONE; RIMEXOLONE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHILD; CLINICAL TRIAL; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ERYTHEMA; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STRABISMUS SURGERY;

ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FLUOROMETHOLONE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; INTRAOCULAR PRESSURE; MALE; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PREGNADIENES; STRABISMUS;

EID: 0345600139     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.121.12.1716     Document Type: Article

References (48)

1. Caldwell JR. Intra-articular corticosteroids: guide to selection and indications for use. Drugs. 1996;52:507-514.
2. Dahan E, Appel R. Vernal keratoconjunctivitis in the black child and its response to therapy. Br J Ophthalmol. 1983;67:688-692.
3. Dunne JA, Travers JP. Double-blind clinical trial of topical steroids in anterior uveitis. Br J Ophthalmol. 1979;63:762-767.
4. Tan DT, Chee SP, Lim L, Lim AS. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation. Ophthalmology. 1999;106:223-231.
5. McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Orug Saf. 2002;25:33-55.
6. Ng JS, Wong W, Law RW, et al. Ocular complications of paediatric patients with nephrotic syndrome. Clin Experiment Ophthalmol. 2001;29:239-243.
7. Convell LL. Glaucoma induced by systemic steroid therapy. Am J Ophthalmol. 1958;45:108-109.
8. Alfano JE. Changes in the intraocular pressure associated with systemic steroid therapy. Am J Ophthalmol. 1963;56:245-247.
9. Cubey RB. Glaucoma following the application of corticosteroid to the skin of the eyelids. Br J Oermatol. 1976;95:207-208.
10. Becker B, Hahn KA. Topical corticosteroids and hereditary in primary open-angle glaucoma. Am J Ophthalmol. 1964;57:543-551.
11. Francois J. Corticosteroid glaucoma. Ann Ophthalmol. 1977;9:1075-1080.
12. Kalina RE. Increased intraocular pressure following subconjunctival corticosteroid administration. Arch Ophthalmol. 1969;81:788-790.
13. Herschler J. Intractable intraocular hypertension induced by repository triamcinolone acetonide. Am J Ophthalmol. 1972;74:501-504.
14. Opatowsky I, Feldman RM, Gross R, Feldman ST. Intraocular pressure elevation associated with inhalation and nasal corticosteroids. Ophthalmology. 1995;102: 177-179.
15. Armaly MF. Statistical attributes of the steroid hypertensive response in the clinically normal eye, I: the demonstration of three level of response. Invest Ophthalmol. 1963;4:187-197.
16. Becker B. Intraocular pressure response to topical steroids. Invest Ophthalmol. 1965;4:198-205.
17. Kwok AK, Lam DS, Ng JS, et al. Ocular-hypertensive response to topical steroids in children. Ophthalmology. 1997;104:2112-2116.
18. Ng JS, Fan DS, Young AL, et al. Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon. Ophthalmology. 2000; 107:2097-2100.
19. Akingbehin AO. Comparative study of the intraocular pressure effects of fluorometholone 0.1% versus dexamethasone 0.1%. Br J Ophthalmol. 1983;67:661-663.
20. Fan DS, Ng JS, Lam DS. A prospective study on ocular hypertensive and antiinflammatory response to different dosages of fluorometholone in children. Ophthalmology. 2001;108:1973-1977.
21. Leibowitz HM, Kupferman A. Bioavailability and therapeutic effectiveness of topically administered corticosteroids. Trans Am Acad Ophthalmol Otolaryngol. 1975; 79:78-88.
22. Solomon KD, Vroman DT, Barker D, Gehlken J. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction: prospective randomized double- masked study. J Cataract Refract Surg. 2001;27:1232-1237.
23. Foster CS, Alter G, DeBarge LR, et al. Efficacy and safety of rimexolone 1% ophthaimic suspension vs 1% prednisolone acetate in the treatment of uveitis. Am J Ophthalmol. 1996;122:171-182.
24. Assil KK, Massry G, Lehmann R, et al. Control of ocular inflammation after cataract extraction with rimexolone 1% ophthaimic suspension. J Cataract Refract Surg. 1997;23:750-757.
25. Leibowitz HM, Bartlett JD, Rich R, et al. Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids. Arch Ophthalmol. 1996; 114:933-937.
26. Eisenberg DL, Sherman BG, McKeown CA, Schuman JS. Tonometry in adults and children: a manometric evaluation of pneumatonometry, applanation, and TonoPen in vitro and in vivo. Ophthalmology. 1998;105:1173-1181.
27. Myers KJ, Lalle P, Litwak A, et al. XPERT NCT-a clinical evaluation. J Am Optom Assoc. 1990;61:863-869.
28. Shields MB. The non-contact tonometer: its value and limitations. Surv Ophthalmol. 1980;24:211-219,
29. Wright M, Butt Z, McIlwaine G, Fleck B. Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery. Br J Ophthalmol. 1997;81: 299-301.
30. Ellis PP. Pharmacological effects of corticosteroids. Int Ophthalmol Clin. 1966; 6:799-819.
31. Godel V, Feiler-Ofry V, Stein R. Systemic steroids and ocular fluid dynamics, 11: systemic versus topical steroids. Acta Ophthalmol (Copenh). 1972;50:664-676.
32. Fairbairn WD, Thorson JC. Fluorometholone: anti-inflammatory and intraocular pressure effects. Arch Ophthalmol. 1971;86:138-141.
33. Kass M, Cheetham J, Duzman E, Burke PJ. The ocular hypertensive effect of 0.25% fluorometholone in corticosteroid responders. Am J Ophthalmol. 1986;102:159-163.
34. Kitazawa Y. Increased intraocular pressure induced by corticosteroids. Am J Ophthalmol. 1976;82:492-495.
35. McEvoy D, ed. AHFS Drug Information, Bethesda, Md: American Society Health-System Pharmacy; 2000:2513-2533.
36. Ohji M, Kinoshita S, Ohmi E, Kuwayama Y. Marked intraocular pressure response to instillation of corticosteroids in children. Am J Ophthalmol. 1991;112: 450-454.
37. Remé C, d'Epinay SL. Periods of development of the normal human chamber angle. Doc Ophthalmol. 1981;51:241-268.
38. Knepper PA, Breen M, Weinstein HG, Blacik JL. Intraocular pressure and glycosaminoglycan distribution in the rabbit eye: effect of age and dexamethasone. Exp Eye Res. 1978;27:567-575.
39. Shepard AR, Jacobson N, Fingert JH, et al. Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2001;42:3173-3181.
40. Lo WR, Rowlette LL, Caballero M, et al. Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma. Invest Ophthalmol Vis Sci. 2003;44:473-485.
41. Lam DS, Leung YF, Chua JK, et al. Truncations in the TIGR gene in individuals with and without primary open-angle glaucoma. Invest Ophthalmol. Vis Sci. 2000; 41:1386-1391.
42. Bhattacherjee P, Paterson CA, Spellman JM, et al. Pharmacological validation of a feline model of steroid-induced ocular hypertension. Arch Ophthalmol. 1999; 117:361-364.
43. Artola A, Ayala MJ, Perez-Santonja JJ, et al. Haze after laser in situ keratomileusis in eyes with previous photorefractive keratectomy. J Cataract Refract Surg. 2001;27:1880-1883.
44. BenEzra D, Wysenbeek YS, Cohen E. Increased intraocular pressure during treatment for chronic uveitis. Graefes Arch Clin Exp Ophthalmol. 1997;235:200-203.
45. Cazabon S, Morrell AJ. Rimexolone-induced intraocular pressure elevation. Eye. 2001;15:663-664.
46. Apt L, Voo I, Isenberg SJ. A randomized clinical trial of the nonsteroidal eyedrop diclofenac after strabismus surgery. Ophthalmology. 1998;105:1448-1452.
47. Kraff MC, Martin RG, Neumann AC, Weinstein AJ. Efficacy of diclofenac sodium ophthalmic solution versus placebo in reducing inflammation following cataract extraction and posterior chamber lens implantation. J Cataract Refract Surg. 1994; 20:138-144.
48. Snir M, Axer-Siegel R, Friling R, Weinberger D. Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery. Ophthalmology. 2000;107: 1884-1888.